Commentary in the American Journal of Psychiatry cautions that the “unbridled enthusiasm” about Ketamine as a “miracle cure” for depression “needs to be tempered by a more rational and guarded perspective,” noting that the drug is already being administered off-label in private psychiatry clinics without regulation by the FDA.
Schatzberg, A., A Word to the Wise About Ketamine. American Journal of Psychiatry. March 1, 2014. 171: 262-264. doi:10.1176/appi.ajp.2014.13101434
Of further interest:
Warning about Ketamine in the American Journal of Psychiatry (The Neurocritic)